With reference to the news reported on moneycontrol on 17/11/2015 --‘USFDA gives Warning Letter to Dishman due to Clovis issues’, Dishman Pharmaceuticals and Chemicals has submitted a copy of Clarification.
The above information is a part of company’s filings submitted to BSE.